
University of Queensland
Also known as: ANZIC-Research Centre; Australian Defence Force, University of Queensland, | Brisbane Public Hospital | Brisbane South Medical Centre | Children's Health Queensland | Dermatology Department, Brisbane Public Hospital | Greenslopes Private Hospital | Isopogen | Lady Cilento Children's Hospital, Brisbane | Nambour General Hospital, Queensland | QIMR Berghofer Medical Research Institute | Queensland Centre for Gynaecological Cancer | Queensland Children's Medical Research Institute | Queensland Children's Medical Research Unit, Herston, AUS | Queensland Institute for Medical Research | Queensland Institute of Medical Research | Redcliffe Hospital, Brisbane, Qld., Australia | Royal Brisbane and Women's Hospital | Royal Brisbane and Womens Hospital | Royal Brisbane and Womens Hospital, Brisbane, Australia | Royal Brisbane & Women's Hospital, QLD, Australia | Royal Brisbane & Women's Hpsoital | The Prince Charles Hospital | The Prince Charles Hospital, Centre for Biodiscovery and Molecular Development of Therapeutics | The Univeristy of Queensland | The University of Queensland | The University of Queensland Centre for Clinical Research | Univeristy of Queensland | University of Queeensland, University of South Australia | University of Queensland, Queensland, Australia | University of Queensland, Queensland Health | University of Queensland & The Prince Charles Hospital | UQCCR
Highest phase reached
Phase 4
First clinical trial
Nov 1, 1998Last known activity
Sep 30, 2025
Timeline
1900s
- Jan 1, 1909
University of Queensland— Founded
Drugs by trial phase (147 distinct, 103 trials)
Phase 4 (35 own, 0 via acquisition)
Phase 3 (37 own, 0 via acquisition)
Phase 2 (36 own, 0 via acquisition)
Phase 1 (26 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Adenocarcinoma
- Amyotrophic Lateral Sclerosis
- Anxiety Disorders
- Ataxia
- Ataxia Telangiectasia
- Atrophy
- Attention Deficit Disorder with Hyperactivity
- Bacteremia
- Bacterial Infections
- Behavior, Addictive
- Blood Loss, Surgical
- Brain Injuries
- Brain Injuries, Traumatic
- Bronchiectasis
- Carcinoma, Endometrioid
- Carcinoma, Ovarian Epithelial
- Celiac Disease
- Cerebellar Ataxia
- Cerebral Palsy
- Cognitive Dysfunction
- Colitis
- Colitis, Ulcerative
- Communicable Diseases
- Coxsackievirus Infections
- Critical Illness
- Crohn Disease
- Cystic Fibrosis
- Delayed Graft Function
- Depression
- Depressive Disorder
- Disease
- Dyskeratosis Congenita
- Endometrial Hyperplasia
- Familial Primary Pulmonary Hypertension
- Fibrosis
- Gram-Positive Bacterial Infections
- Hemolysis
- Hemorrhage
- Hyperkinesis
- Hyperplasia
- Hypertension
- Hypotension
- Hypotension, Orthostatic
- Infections
- Inflammatory Bowel Diseases
- Intestinal Diseases
- Keratosis
- Keratosis, Actinic
- Kidney Diseases
- Kidney Failure, Chronic
- Lice Infestations
- Lung Diseases
- Lung Diseases, Obstructive
- Lymphoma
- Major Depressive Disorder
- Malaria
- Malaria, Falciparum
- Melanoma
- Motor Neuron Disease
- Multiple System Atrophy
- Multiple Trauma
- Mycobacterium Infections
- Mycoses
- Nematode Infections
- Ovarian Neoplasms
- Parkinson Disease
- Pharyngitis
- Pneumonia
- Proctitis
- Prostatic Neoplasms
- Pulmonary Fibrosis
- Respiratory Syncytial Virus Infections
- Sclerosis
- Shy-Drager Syndrome
- Streptococcal Infections
- Telangiectasis
- Ulcer
- Uterine Neoplasms
- Virus Diseases
- Wound Infection
- Wounds and Injuries
Recent trials (50)
- NCT07101055CollaboratorPhase 1Sep 30, 2025
- NCT07101055Lead sponsorPhase 1Sep 30, 2025
- NCT07101055OfficialPhase 1Sep 30, 2025
- NCT07101055Sponsor investigatorPhase 1Sep 30, 2025
- NCT06992141CollaboratorEarly Phase 1Jul 24, 2025
- NCT06993103CollaboratorPhase 4Jun 2, 2025
- NCT06993103Lead sponsorPhase 4Jun 2, 2025
- NCT06522854CollaboratorPhase 2May 1, 2025
- NCT06676384OfficialPhase 4Nov 30, 2024
- NCT06120673Lead sponsorPhase 3Jul 31, 2024
- NCT06278857Lead sponsorPhase 2Jun 1, 2024
- NCT06324877Lead sponsorN/AMay 1, 2024
- NCT06157541Overall official - principal investigatorPhase 1/Phase 2Jan 31, 2024
- NCT06157541Lead sponsorPhase 1/Phase 2Jan 31, 2024
- NCT06157541OfficialPhase 1/Phase 2Jan 31, 2024
Details
- Founded
- Brisbane, AU Jan 1, 1909
- Last known activity
- Sep 30, 2025